|
|
Previous Article | Table of Contents | Next Article 
Synthesis of transforming growth factor-beta 1 by megakaryocytes and its
localization to megakaryocyte and platelet alpha-granules
RA Fava, TT Casey, J Wilcox, RW Pelton, HL Moses and LB Nanney
Department of Cell Biology, Vanderbilt University School of Medicine,
Nashville, TN.
We have directly demonstrated that megakaryocytes are a major site of
synthesis and storage of transforming growth factor-beta 1 (TGF/beta 1) by
combined immunohistochemical, immunocytochemical, and in situ hybridization
methods. The presence of TGF/beta 1 messenger RNA (mRNA) in mature
megakaryocytes in adult rat spleen and bone marrow (BM) was established by
in situ hybridization. Localization of TGF/beta 1 protein to intact
alpha-granules of megakaryocytes, its putative storage site, was
accomplished in glycol-methacrylate embedded porcine BM with an
immunoperoxidase technique and light microscopy. The TGF/beta 1 was
sequestered in intracytoplasmic granules in a pattern virtually identical
to that of another alpha-granule marker protein, fibrinogen. This
observation strongly suggests packaging of TGF/beta 1 into this organelle
within megakaryocytes. That TGF/beta 1 mRNA was localized to megakaryocytes
suggests that the TGF/beta 1 found in the alpha-granules in platelets
originates with megakaryocyte synthesis. The alpha-granule localization of
TGF/beta 1, as well as fibrinogen, was also demonstrated in isolated
platelets at the ultrastructural level by electronmicroscopy (EM) and
postembedding colloidal-gold immunocytochemistry, thus directly
demonstrating that alpha-granules are the final storage site for TGF/beta 1
in mature platelets.
Volume 76,
Issue 10,
pp. 1946-1955,
11/15/1990
Copyright © 1990 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Garimella, M. A. Kacena, S. E. Tague, J. Wang, M. C. Horowitz, and H. C. Anderson
Expression of Bone Morphogenetic Proteins and Their Receptors in the Bone Marrow Megakaryocytes of GATA-1low Mice: A Possible Role in Osteosclerosis
J. Histochem. Cytochem.,
July 1, 2007;
55(7):
745 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Akyurek, L Atahan, M Cengiz, C Sokmensuer, I Haberal, F Yildiz, and C Onal
Effect of ticlopidine in the prevention of radiation enteropathy
Br. J. Radiol.,
May 1, 2006;
79(941):
409 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-H. Laprise, F. Grondin, P. Cayer, P. P. McDonald, and C. M. Dubois
Furin gene (fur) regulation in differentiating human megakaryoblastic Dami cells: involvement of the proximal GATA recognition motif in the P1 promoter and impact on the maturation of furin substrates
Blood,
November 15, 2002;
100(10):
3578 - 3587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Houlihan, A. Akdeniz, C. Tsalamandris, M. E. Cooper, G. Jerums, and R. E. Gilbert
Urinary Transforming Growth Factor-{beta} Excretion in Patients With Hypertension, Type 2 Diabetes, and Elevated Albumin Excretion Rate: Effects of angiotensin receptor blockade and sodium restriction
Diabetes Care,
June 1, 2002;
25(6):
1072 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Catani, M. Amabile, S. Luatti, L. Valdre, N. Vianelli, G. Martinelli, and S. Tura
Interleukin-4 Downregulates Nuclear Factor-Erythroid 2 (NF-E2) Expression in Primary Megakaryocytes and in Megakaryoblastic Cell Lines
Stem Cells,
July 1, 2001;
19(4):
339 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld
Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis
Blood,
September 15, 2000;
96(6):
2022 - 2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakamaki, Y. Hirayama, T. Matsunaga, H. Kuroda, T. Kusakabe, T. Akiyama, Y. Konuma, K. Sasaki, N. Tsuji, T. Okamoto, et al.
Transforming Growth Factor-beta 1 (TGF-beta 1) Induces Thrombopoietin From Bone Marrow Stromal Cells, Which Stimulates the Expression of TGF-beta Receptor on Megakaryocytes and, in Turn, Renders Them Susceptible to Suppression by TGF-beta Itself With High Specificity
Blood,
September 15, 1999;
94(6):
1961 - 1970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Z. Chen, G. M. Hochwald, C. Huang, G. Dakin, H. Tao, C. Cheng, W. J. Simmons, G. Dranoff, and G. J. Thorbecke
Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta 1
PNAS,
October 13, 1998;
95(21):
12516 - 12521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Robledo, F. Sanz-Rodriguez, A. Hidalgo, and J. Teixido
Differential Use of Very Late Antigen-4 and -5 Integrins by Hematopoietic Precursors and Myeloma Cells to Adhere to Transforming Growth Factor-beta 1-treated Bone Marrow Stroma
J. Biol. Chem.,
May 15, 1998;
273(20):
12056 - 12060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. HUGHES
Modulating the immune response in demyelinating diseases
J. Neurol. Neurosurg. Psychiatry,
February 1, 1998;
64(2):
148 - 148.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chan and E. M. Spencer
Megakaryocytes Endocytose Insulin-Like Growth Factor (IGF) I and IGF-Binding Protein-3: A Novel Mechanism Directing Them into {alpha} Granules of Platelets
Endocrinology,
February 1, 1998;
139(2):
559 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|